Glaucoma is the second leading cause of blindness worldwide. Although it can be treated, new research shows Canadians may not be doing enough to protect themselves. According to a new study by Lawson Health Research Institute’s Dr. Cindy Hutnik, many C…
Category: News
‘Pink Eye’ Epidemic Has Potential Treatment
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) – sometimes called “pink eye” – a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Th…
DSMB authorizes ACT to proceed with next set of patients in stem cell clinical trials
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company’s two ongoing stem cell clinical trials in the United States authorized …
A 65-Year-Old Man With a Chronic Red Eye
A 65-year-old man presents with a chronic red eye that has not improved with treatment. What is your diagnosis? Medscape Ophthalmology
Optimal Algorithm Developed For Determining Focus Error In Eyes And Cameras
University of Texas at Austin researchers have discovered how to extract and use information in an individual image to determine how far objects are from the focus distance, a feat only accomplished by human and animal visual systems until now. Like a …
When Cellulitis Doesn’t Resolve: A Mysterious Case
Paul G. Auwaerter, MD, describes a case of facial cellulitis that would not get better and the observation that finally solved the mystery. Medscape Infectious Diseases
A Girl With a Brow Mass
What condition do you suspect is present in this 3-year-old girl with a mass on her brow? Medscape Ophthalmology
A Treatment For One Form Of Albinism?
Individuals with oculocutaneous albinism, type 1 (OCA1) have white hair, very pale skin, and light-colored irises because they have none, or very little, of the pigment melanin in their skin, hair, and eyes. Affected individuals have impaired eyesight …
Melanoma Patients Receive Extra Months Of Disease-Free Life Following Infusing Chemotherapy Into The Liver
Melanoma of the eye (ocular or uveal melanoma) frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients live for a year…
Embryonic stem cell therapy for incurable Stargardt eye disease
Extra Months Of Disease-Free Life For Melanoma Patients Delivered By New Treatment
Once melanoma of the eye (ocular or uveal melanoma) spreads to the liver, which happens frequently, no effective treatment is available and often the individuals die within two to four months on average, with only one in ten surviving for a year…
UK OK’s Embryonic Stem Cell Trial for Eye Disease
British drug regulators have granted approval to Advanced Cell Technology to conduct the first trial in Europe of human embryonic stem cells, testing the cells in people with a progressive form of blindness, the firm said on Thursday. Reuters Health …
Canon CR-2 PLUS Non-mydriatic Retinal Camera Coming to U.S.
Having secured FDA clearance, Canon is now releasing its CR-2 PLUS digital non-mydriatic retinal camera to the U.S. market. The main feature of the camera over the CR-2 model is its ability to do fundus autofluorescence photography that is used to detect macular residue such as lipofuscin that gathers in the retinal pigment epithelial layer.
Like some other Canon retinal cameras, the CR-2 PLUS uses a common Rebel digital SLR as the image sensor.
New Twist Uncovered In A Blindness-Causing Disease Gene
After more than three decades of research, University of Pennsylvania veterinarians and vision-research scientists, with associates at Cornell University, have identified a gene responsible for a blindness-inducing disease that afflicts dogs. In the pr…
STAAR’s new Visian ICL with CentraFLOW technology showcased at ESCRS congress
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the Visian Implantable Collamer Lens (ICL), and new Visian ICL with CentraFLOW technology utilizing the KS-AquaPORT, were …
First European Human Embryonic Stem Cell Trial Gets Go Ahead
The European authorities have given the go ahead for trials to treat patients with Stargardt’s Macular Dystrophy (SMD) using retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs). If successful, the trial may pave the way…
AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1.5 million from the Foundation Fighting Blindness to fu…
OPKO Announces Sale of Ophthalmic Instrumentation Business
MIAMI–(BUSINESS WIRE)–OPKO Health, Inc. (NYSE: OPK) has agreed to sell its ophthalmic instrumentation business to OPTOS, Inc., a subsidiary of Optos plc, a leading and rapidly growing medical technology company engaged in the design, development, man…
AGTC Receives Grant from the Foundation Fighting Blindness for Pre-Clinical Study of Gene Therapy for Eye Disease
GAINESVILLE, Fla.–(BUSINESS WIRE)–AGTC receives significant grant funding from the Foundation Fighting Blindness to develop treatment for genetic eye disease, XLRS, causing blindness in young boys.
Canaloplasty an Option in Open-Angle Glaucoma
Canaloplasty works just as well as trabeculectomy in reducing intraocular pressure (IOP) in patients with open-angle glaucoma, according to a comparative case series in Ophthalmology.